Series A - Gero

Series A - Gero

Investment Firm

Overview

Gero is a biotechnology company that provides therapeutics against chronic diseases.

Announced Date

Oct 18, 2023

Funding Type

Series A

Highlights

Location

Asia

Social

Investor Lead

Melnichek Investments

Melnichek Investments

Melnichek Investments is a early_stage_venture and venture firm.

Participant Investors

3

Investor Name
Participant InvestorMelnichek Investments
Participant InvestorLeo Lozner
Participant InvestorVitaDAO

Round Details and Background

Gero raised $6000000 on 2023-10-18 in Series A

Gero is a biotechnology company that provides therapeutics against chronic diseases.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 05, 2019
Seed Round - Gero
1-undefined
Aug 04, 2020
Series A - Gero
1-undefined
Oct 18, 2023
Series A - Gero
3-6.0M

Recent Activity

There is no recent news or activity for this profile.